HMA-Venetoclax Induction in Newly Diagnosed AML
Clinical trial NCT07748455 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07748455
- Sponsor
- Pakistan Blood and Marrow Transplant (PBMT) Group
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.